null - FindTrial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224631

Enrollment

Registered

2019-04-10

Start date

2019-04-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 391 Agents for liver disease Dosage and Administration for Investigational material : Si

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
pharmacokinetics	—

Secondary

Measure	Time frame
safety other	—

Countries

Japan

Outcome results